Long-Term Efficacy, Complete Scalp Hair Regrowth, and Normal Body Hair and Nails in Patients with Alopecia Areata Receiving Ritlecitinib 50 mg Once Daily Up to 3 Years in the ALLEGRO Clinical Trial Program

    Brett King, Rodney Sinclair, Lidia Rudnicka … Alexandre Lejeune
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on jaad.org →
    Discuss this study in the Community →